Lexeo Therapeutics, Inc. Common Stock
LXEO
$2.74-9.87%
End of day · as of Oct 14, 2026, 12:30 AM ET
Mkt cap
$147.70M
EV/Sales
129.5
P/E ratio
N/A
FY2022 Revenue
$654,000
EPS (H1 2026)
$-0.55
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
9063.76%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported LXEO revenue for 2022-12-31 was $654.0K. Net income was $59.3M. LXEO currently screens at market cap $147.7M.
Use this LXEO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LXEO income, balance, and cash tables.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company in the Healthcare sector.
Latest cached Lexeo Therapeutics, Inc. Common Stock (LXEO) revenue for Dec 31, 2022 was $654.0K. Net income was $59.3M. Statements: https://lician.com/financials/lxeo
Lexeo Therapeutics, Inc. Common Stock (LXEO) market capitalization is $147.7M on the latest cached snapshot.
Lexeo Therapeutics, Inc. Common Stock (LXEO) cached previous close $3.04; day range $2.74 – $3.03; volume 1,576,716. Session quote: https://lician.com/quote/lxeo
Lexeo Therapeutics, Inc. Common Stock (LXEO) latest cached earnings event is "LXEO earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LXEO filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/lxeo